This inventor holds 9 USPTO granted patents and 3 EPO patents. Top assignee: Hisamitsu Pharmaceutical Company, Inc.. Active years: 1998-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tosu, JP (1998)
- Tsukuba, JP (1999 - 2010)
- Ibaraki, JP (2013)
Company Filing History:
Years Active: 1998-2013
Title: Mitsuru Kuribayashi: Innovator in Transdermal Drug Delivery
Introduction
Mitsuru Kuribayashi, based in Tsukuba, Japan, is a prominent inventor known for his significant contributions to the field of pharmaceutical innovations. With an impressive portfolio of 9 patents, Kuribayashi has focused on enhancing drug delivery systems, particularly through transdermal applications.
Latest Patents
Kuribayashi's latest inventions include a "Transdermally absorbable preparation," which addresses the challenge of poor solubility in drug formulations by ensuring stability over time while suppressing crystallization. This innovative preparation includes composite particles made up of a silicate compound, an organic acid, and a drug to optimize transdermal absorbability. Additionally, he developed a "Drug-containing patch" that presents an effective solution for percutaneous absorbability and sustainability of the drug’s efficacy. This patch comprises a drug, a melting point lowering agent, and an adhesive base, making it suitable for therapeutic use in patients.
Career Highlights
Currently, Mitsuru Kuribayashi is affiliated with Hisamitsu Pharmaceutical Company, Inc., where he continues to pioneer advancements in transdermal drug delivery systems. His work has been instrumental in enhancing therapeutic outcomes for patients needing effective and reliable drug administration methods.
Collaborations
Throughout his career, Kuribayashi has collaborated with notable colleagues, including Naruhito Higo and Hiroyuki Maeda. These partnerships have contributed to the successful development of innovative drug delivery solutions.
Conclusion
Mitsuru Kuribayashi exemplifies the spirit of innovation in the pharmaceutical industry. His continuous efforts to develop advanced transdermal systems will likely inspire future breakthroughs in drug delivery, ultimately benefiting patients around the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile